{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T02:16:00Z","timestamp":1784772960043,"version":"3.55.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T00:00:00Z","timestamp":1610064000000},"content-version":"vor","delay-in-days":373,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001116","name":"Foundation Fighting Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001116","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Van Sloun Fund for Canine Genetic Research"},{"DOI":"10.13039\/100006312","name":"BrightFocus Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006312","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Vice Provost for Research at the University of Pennsylvania"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.ymthe.2019.08.013","type":"journal-article","created":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T23:21:48Z","timestamp":1567552908000},"page":"266-278","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["Long-Term Structural Outcomes of Late-Stage RPE65 Gene Therapy"],"prefix":"10.1016","volume":"28","author":[{"given":"Kristin L.","family":"Gardiner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artur V.","family":"Cideciyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Swider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie L.","family":"Dufour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Sumaroka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e1s M.","family":"Kom\u00e1romy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William W.","family":"Hauswirth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Iwabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel G.","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Beltran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo D.","family":"Aguirre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2019.08.013_bib1","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/3813","article-title":"Rpe65 is necessary for production of 11-cis-vitamin A in the retinal visual cycle","volume":"20","author":"Redmond","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2019.08.013_bib2","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/ng0501-92","article-title":"Gene therapy restores vision in a canine model of childhood blindness","volume":"28","author":"Acland","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2019.08.013_bib3","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ymthe.2003.11.013","article-title":"In utero gene therapy rescues vision in a murine model of congenital blindness","volume":"9","author":"Dejneka","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2019.08.013_bib4","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.ymthe.2005.08.008","article-title":"Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness","volume":"12","author":"Acland","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2019.08.013_bib5","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1056\/NEJMoa0802268","article-title":"Effect of gene therapy on visual function in Leber\u2019s congenital amaurosis","volume":"358","author":"Bainbridge","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2019.08.013_bib6","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1056\/NEJMoa0802315","article-title":"Safety and efficacy of gene transfer for Leber\u2019s congenital amaurosis","volume":"358","author":"Maguire","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2019.08.013_bib7","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1089\/hum.2008.107","article-title":"Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial","volume":"19","author":"Hauswirth","year":"2008","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2019.08.013_bib8","doi-asserted-by":"crossref","first-page":"15112","DOI":"10.1073\/pnas.0807027105","article-title":"Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics","volume":"105","author":"Cideciyan","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2019.08.013_bib9","doi-asserted-by":"crossref","first-page":"E517","DOI":"10.1073\/pnas.1218933110","article-title":"Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement","volume":"110","author":"Cideciyan","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2019.08.013_bib10","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa1412965","article-title":"Improvement and decline in vision with gene therapy in childhood blindness","volume":"372","author":"Jacobson","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2019.08.013_bib11","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJMoa1414221","article-title":"Long-term effect of gene therapy on Leber\u2019s congenital amaurosis","volume":"372","author":"Bainbridge","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2019.08.013_bib12","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(17)31868-8","article-title":"Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial","volume":"390","author":"Russell","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2019.08.013_bib13","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.ophtha.2019.06.017","article-title":"Efficacy, safety, and durability of voretigene neparvovec-rzyl in RPE65 mutation-associated inherited retinal dystrophy: Results of phase 1 and 3 trials","volume":"126","author":"Maguire","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2019.08.013_bib14","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.preteyeres.2010.04.002","article-title":"Leber congenital amaurosis due to RPE65 mutations and its treatment with gene therapy","volume":"29","author":"Cideciyan","year":"2010","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ymthe.2019.08.013_bib15","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.ophtha.2017.01.029","article-title":"The role of the human visual cortex in assessment of the long-term durability of retinal gene therapy in follow-on RPE65 clinical trial patients","volume":"124","author":"Ashtari","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2019.08.013_bib16","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/ng1097-194","article-title":"Mutations in RPE65 cause autosomal recessive childhood-onset severe retinal dystrophy","volume":"17","author":"Gu","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2019.08.013_bib17","first-page":"23","article-title":"Congenital stationary night blindness in the dog: common mutation in the RPE65 gene indicates founder effect","volume":"4","author":"Aguirre","year":"1998","journal-title":"Mol. Vis."},{"key":"10.1016\/j.ymthe.2019.08.013_bib18","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1167\/iovs.02-0595","article-title":"Functional and structural recovery of the retina after gene therapy in the RPE65 null mutation dog","volume":"44","author":"Narfstr\u00f6m","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2019.08.013_bib19","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.ymthe.2006.03.005","article-title":"Safety of recombinant adeno-associated virus type 2-RPE65 vector delivered by ocular subretinal injection","volume":"13","author":"Jacobson","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2019.08.013_bib20","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/sj.gt.3302861","article-title":"Restoration of vision in RPE65-deficient Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epithelium","volume":"14","author":"Le Meur","year":"2007","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2019.08.013_bib21","doi-asserted-by":"crossref","first-page":"e230","DOI":"10.1371\/journal.pmed.0040230","article-title":"Canine and human visual cortex intact and responsive despite early retinal blindness from RPE65 mutation","volume":"4","author":"Aguirre","year":"2007","journal-title":"PLoS Med."},{"key":"10.1016\/j.ymthe.2019.08.013_bib22","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF01203343","article-title":"Slowly progressive changes of the retina and retinal pigment epithelium in Briard dogs with hereditary retinal dystrophy. A morphological study","volume":"87","author":"Wrigstad","year":"1994","journal-title":"Doc. Ophthalmol."},{"key":"10.1016\/j.ymthe.2019.08.013_bib23","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1167\/iovs.08-2121","article-title":"Photoreceptor layer topography in children with leber congenital amaurosis caused by RPE65 mutations","volume":"49","author":"Jacobson","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2019.08.013_bib24","doi-asserted-by":"crossref","first-page":"e90390","DOI":"10.1371\/journal.pone.0090390","article-title":"Canine retina has a primate\u00a0fovea-like bouquet of cone photoreceptors which is affected by inherited macular degenerations","volume":"9","author":"Beltran","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2019.08.013_bib25","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1167\/iovs.05-0965","article-title":"RPE65 gene delivery restores isomerohydrolase activity and prevents early cone loss in Rpe65-\/- mice","volume":"47","author":"Chen","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2019.08.013_bib26","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1089\/hum.2006.17.845","article-title":"Safety in nonhuman primates of ocular AAV2-RPE65, a candidate treatment for blindness in Leber congenital amaurosis","volume":"17","author":"Jacobson","year":"2006","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2019.08.013_bib27","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1016\/j.visres.2009.04.008","article-title":"Naturally occurring animal models with outer retina phenotypes","volume":"49","author":"Baehr","year":"2009","journal-title":"Vision Res."},{"key":"10.1016\/j.ymthe.2019.08.013_bib28","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1089\/humc.2014.155","article-title":"Dog models for blinding inherited retinal dystrophies","volume":"26","author":"Petersen-Jones","year":"2015","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"10.1016\/j.ymthe.2019.08.013_bib29","doi-asserted-by":"crossref","first-page":"E8547","DOI":"10.1073\/pnas.1805055115","article-title":"Mutation-independent rhodopsin gene therapy by knockdown and replacement with a single AAV vector","volume":"115","author":"Cideciyan","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2019.08.013_bib30","doi-asserted-by":"crossref","first-page":"E2839","DOI":"10.1073\/pnas.1720662115","article-title":"BEST1 gene therapy corrects a diffuse retina-wide microdetachment modulated by light exposure","volume":"115","author":"Guziewicz","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2019.08.013_bib31","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1517\/21678707.2015.1030393","article-title":"Improvement in vision: a new goal for treatment of hereditary retinal degenerations","volume":"3","author":"Jacobson","year":"2015","journal-title":"Expert Opin. Orphan Drugs"},{"key":"10.1016\/j.ymthe.2019.08.013_bib32","series-title":"The Forever Fix: Gene Therapy and the Boy Who Saved It","author":"Lewis","year":"2012"},{"key":"10.1016\/j.ymthe.2019.08.013_bib33","doi-asserted-by":"crossref","first-page":"175fs8","DOI":"10.1126\/scitranslmed.3005798","article-title":"Seeing the light","volume":"5","author":"Wojno","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2019.08.013_bib34","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/sj.mt.6300389","article-title":"Reversal of blindness in animal models of leber congenital amaurosis using optimized AAV2-mediated gene transfer","volume":"16","author":"Bennicelli","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2019.08.013_bib35","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/gt.2012.63","article-title":"RPE65 gene therapy slows cone loss in Rpe65-deficient dogs","volume":"20","author":"Mowat","year":"2013","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2019.08.013_bib36","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1073\/pnas.0500646102","article-title":"Identifying photoreceptors in blind eyes caused by RPE65 mutations: Prerequisite for human gene therapy success","volume":"102","author":"Jacobson","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2019.08.013_bib37","doi-asserted-by":"crossref","first-page":"15123","DOI":"10.1073\/pnas.0706367104","article-title":"Human cone photoreceptor dependence on RPE65 isomerase","volume":"104","author":"Jacobson","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2019.08.013_bib38","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1167\/iovs.08-2696","article-title":"Defining the residual vision in leber congenital amaurosis caused by RPE65 mutations","volume":"50","author":"Jacobson","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2019.08.013_bib39","doi-asserted-by":"crossref","first-page":"5304","DOI":"10.1167\/iovs.10-5559","article-title":"Retinal disease in Rpe65-deficient mice: comparison to human leber congenital amaurosis due to RPE65 mutations","volume":"51","author":"Caruso","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2019.08.013_bib40","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/S0140-6736(09)61836-5","article-title":"Age-dependent effects of RPE65 gene therapy for Leber\u2019s congenital amaurosis: a phase 1 dose-escalation trial","volume":"374","author":"Maguire","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2019.08.013_bib41","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/archophthalmol.2011.298","article-title":"Gene therapy for leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years","volume":"130","author":"Jacobson","year":"2012","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ymthe.2019.08.013_bib42","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1167\/iovs.17-21930","article-title":"Early-onset progressive degeneration of the area centralis in RPE65-deficient dogs","volume":"58","author":"Mowat","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2019.08.013_bib43","first-page":"2518","article-title":"Topographical characterization of cone photoreceptors and the area centralis of the canine retina","volume":"14","author":"Mowat","year":"2008","journal-title":"Mol. Vis."},{"key":"10.1016\/j.ymthe.2019.08.013_bib44","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1093\/hmg\/ddq136","article-title":"Gene therapy\u00a0rescues cone function in congenital achromatopsia","volume":"19","author":"Kom\u00e1romy","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2019.08.013_bib45","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1073\/pnas.1118847109","article-title":"Gene therapy rescues photoreceptor blindness in dogs and paves the way for treating human X-linked retinitis pigmentosa","volume":"109","author":"Beltran","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2019.08.013_bib46","first-page":"337","article-title":"Biochemistry of visual pigment regeneration: the Friedenwald lecture","volume":"41","author":"Saari","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2019.08.013_bib47","first-page":"7","article-title":"Interphotoreceptor retinoid-binding protein (IRBP): a model protein for molecular biological and clinically relevant studies. Friedenwald lecture","volume":"30","author":"Chader","year":"1989","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2019.08.013_bib48","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1124\/mol.117.111294","article-title":"Retinal-chitosan conjugates effectively deliver active chromophores to retinal photoreceptor cells in blind mice and dogs","volume":"93","author":"Gao","year":"2018","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ymthe.2019.08.013_bib49","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1006\/exer.1996.0257","article-title":"Differential expression of photoreceptor-specific proteins during disease and degeneration in the progressive rod-cone degeneration (prcd) retina","volume":"64","author":"Gropp","year":"1997","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ymthe.2019.08.013_bib50","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1523\/JNEUROSCI.12-09-03554.1992","article-title":"Basic fibroblast growth factor and local injury protect photoreceptors from light damage in the rat","volume":"12","author":"Faktorovich","year":"1992","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ymthe.2019.08.013_bib51","doi-asserted-by":"crossref","first-page":"E5844","DOI":"10.1073\/pnas.1509914112","article-title":"Successful arrest of photoreceptor and vision loss expands the therapeutic window of retinal gene therapy to later stages of disease","volume":"112","author":"Beltran","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2019.08.013_bib52","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3727\/000000006783981701","article-title":"Application of a new subretinal injection device in the dog","volume":"15","author":"Kom\u00e1romy","year":"2006","journal-title":"Cell Transplant."},{"key":"10.1016\/j.ymthe.2019.08.013_bib53","doi-asserted-by":"crossref","first-page":"e24074","DOI":"10.1371\/journal.pone.0024074","article-title":"Photoreceptor cell death, proliferation and formation of hybrid rod\/S-cone photoreceptors in the degenerating STK38L mutant retina","volume":"6","author":"Berta","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2019.08.013_bib54","doi-asserted-by":"crossref","first-page":"e85408","DOI":"10.1371\/journal.pone.0085408","article-title":"Up-regulation of tumor necrosis factor superfamily genes in early phases of photoreceptor degeneration","volume":"8","author":"Genini","year":"2013","journal-title":"PLoS ONE"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152500161930396X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152500161930396X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:28:25Z","timestamp":1736987305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152500161930396X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S152500161930396X"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2019.08.013","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-Term Structural Outcomes of Late-Stage RPE65 Gene Therapy","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2019.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}